Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer
- PMID: 16947084
- DOI: 10.1007/s10911-006-9010-8
Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer
Abstract
The peptide growth factors IGF-I and IGF-II not only play a role in the development of the mammary gland but are also implicated in breast cancer. Several reagents disrupting IGF signaling have been developed and clinical trials validating IGF signaling as a target in cancer therapy are underway. This review highlights the approaches to inhibiting IGF signaling in breast cancer.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
